Difference between revisions of "Part:BBa K2812003"

 
Line 3: Line 3:
 
<partinfo>BBa_K2812003 short</partinfo>
 
<partinfo>BBa_K2812003 short</partinfo>
  
−
This biobrick contains the coding domain for truncated lysostaphin. Lysostaphin targets the cell wall peptidoglycan found in certain Staphylococci by cleaving its cross-linking pentaglycine bridges. Among others, it is effective for degrading S. aureus biofilm. In this biobrick, lysostaphin production is regulated by the T7 promoter. Expression can be induced by the presence of isopropyl &#946;-D-1-thiogalactopyranoside (IPTG).
+
 
 +
 
 +
The biobrick contains the coding domain for truncated lysostaphin, based on the coding sequence derived from <partinfo>BBa_K748002</partinfo>. In this biobrick, lysostaphin production is regulated by the T7 promoter BBa_k525998. Expression can be induced by the presence of isopropyl &#946;-D-1-thiogalactopyranoside (IPTG). TU-Eindhoven 2018 used this part to produce lysostaphin from ''Escherichia coli'' to kill ''Staphylococcus aureus'' biofilms for the treatment of wound infections. For more information about our project, please visit our [http://2018.igem.org/Team:TU-Eindhoven wiki]. 
 +
 
 +
===Usage & Biology===
 +
====Lysostaphin====
 +
Lysostaphin is an antimicrobial agent produced by ''Staphylococcus simulans''. It targets the cell wall peptidoglycan found in certain Staphylococci by cleaving its cross-linking pentaglycine bridges. Among others, it is effective for degrading Staphylocuccus aureus biofilms.<sup>1</sup> The encoding part of the lysostaphin has been derived from <partinfo>BBa_K748002</partinfo>, which was made by iGEM Harbin 2012 and was also used by iGEM Stockholm 2016. iGEM Eindhoven 2018 codon optimized this lysostaphin construct. Lysostaphin belongs to the major class of antimicrobial proteins and peptides known as bacteriocins. Bacteriocins are proteins or peptides produced by bacteria, displaying a bactericidal activity against other subpopulations of bacteria.<sup>2</sup> The cell wall degradation capability of lysostaphin derives from its endopeptidase activity on pentaglycine cross-bridges in the peptidoglycan layer. Specific cleavage between the third and fourth glycine residue leads to the destruction of the peptidoglycan layer and subsequent lysis of the bacteria.
 +
 
 +
====Sources====
 +
1) Tossavainen, H., Raulinaitis, V., Kauppinen, L., Pentikäinen, U., Maaheimo, H., & Permi, P. (2018). Structural and Functional Insights Into Lysostaphin–Substrate Interaction. ''Front Mol Biosci''.
 +
 
 +
2) Bastos, M. d., Coutinho, B. G., & Coelho, M. L. (2010). Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications. Pharmaceuticals (Basel) , 1139–1161.
  
 
<!-- Add more about the biology of this part here
 
<!-- Add more about the biology of this part here

Revision as of 21:04, 16 October 2018


Coding sequence for trunctated Lysostaphin regulated by T7-promoter


The biobrick contains the coding domain for truncated lysostaphin, based on the coding sequence derived from BBa_K748002. In this biobrick, lysostaphin production is regulated by the T7 promoter BBa_k525998. Expression can be induced by the presence of isopropyl β-D-1-thiogalactopyranoside (IPTG). TU-Eindhoven 2018 used this part to produce lysostaphin from Escherichia coli to kill Staphylococcus aureus biofilms for the treatment of wound infections. For more information about our project, please visit our [http://2018.igem.org/Team:TU-Eindhoven wiki].

Usage & Biology

Lysostaphin

Lysostaphin is an antimicrobial agent produced by Staphylococcus simulans. It targets the cell wall peptidoglycan found in certain Staphylococci by cleaving its cross-linking pentaglycine bridges. Among others, it is effective for degrading Staphylocuccus aureus biofilms.1 The encoding part of the lysostaphin has been derived from BBa_K748002, which was made by iGEM Harbin 2012 and was also used by iGEM Stockholm 2016. iGEM Eindhoven 2018 codon optimized this lysostaphin construct. Lysostaphin belongs to the major class of antimicrobial proteins and peptides known as bacteriocins. Bacteriocins are proteins or peptides produced by bacteria, displaying a bactericidal activity against other subpopulations of bacteria.2 The cell wall degradation capability of lysostaphin derives from its endopeptidase activity on pentaglycine cross-bridges in the peptidoglycan layer. Specific cleavage between the third and fourth glycine residue leads to the destruction of the peptidoglycan layer and subsequent lysis of the bacteria.

Sources

1) Tossavainen, H., Raulinaitis, V., Kauppinen, L., Pentikäinen, U., Maaheimo, H., & Permi, P. (2018). Structural and Functional Insights Into Lysostaphin–Substrate Interaction. Front Mol Biosci.

2) Bastos, M. d., Coutinho, B. G., & Coelho, M. L. (2010). Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications. Pharmaceuticals (Basel) , 1139–1161.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal AgeI site found at 164
  • 1000
    COMPATIBLE WITH RFC[1000]